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Abstract
Background: There is mounting experimental evidence that hypercapnic acidosis protects against lung injury.
However, it is unclear if acidosis per se rather than hypercapnia is responsible for this beneficial effect. Therefore,
we sought to evaluate the effects of hypercapnic (respiratory) versus normocapnic (metabolic) acidosis in an ex
vivo model of ventilator-induced lung injury (VILI).
Methods: Sixty New Zealand white rabbit ventilated and perfused heart-lung preparations were used. Six study
groups were evaluated. Respiratory acidosis (RA), metabolic acidosis (MA) and normocapnic-normoxic (Control - C)
groups were randomized into high and low peak inspiratory pressures, respectively. Each preparation was
ventilated for 1 hour according to a standardized ventilation protocol. Lung injury was evaluated by means of
pulmonary edema formation (weight gain), changes in ultrafiltration coefficient, mean pulmonary artery pressure
changes as well as histological alterations.
Results: HPC group gained significantly greater weight than HPMA, HPRA and all three LP groups (P = 0.024),
while no difference was observed between HPMA and HPRA groups regarding weight gain. Neither group differ
on ultrafiltration coefficient. HPMA group experienced greater increase in the mean pulmonary artery pressure at
20 min (P = 0.0276) and 40 min (P = 0.0012) compared with all other groups. Histology scores were significantly
greater in HP vs. LP groups (p < 0.001).
Conclusions: In our experimental VILI model both metabolic acidosis and hypercapnic acidosis attenuated VILI-
induced pulmonary edema implying a mechanism other than possible synergistic effects of acidosis with CO2 for
VILI attenuation.
Background
The ARDS Network study [1] documented that a low
tidal volume (VT) of 6 ml/kg has beneficial effects on
outcomes compared to the traditionally used volume of
12 ml/kg. However, these “protective” ventilation strate-
gies may lead to the development of hypercapnic acido-
sis (HA), a fact initially viewed as an undesirable side
effect to be corrected. Since low VT ventilation is now
increasingly used in order to minimize ventilator-
induced lung injury (VILI), hypercapnic acidosis, also
termed “permissive hypercapnia”,i sf r e q u e n t l yc o n -
fronted by clinicians. Either a side-effect to be tolerated
or a desirable beneficial event, hypercapnic acidosis is
still an intriguing issue having received much debate.
The mounting experimental evidence for a beneficial
effect of respiratory acidosis on the function of multiple
organs [2] has encouraged clinicians to use low VT and
peak pressure ventilation strategies in an attempt to let
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blood. However, it should be noted that there are no
specific guidelines concerning the use of hypercapnic
acidosis in clinical practice. Limited data exist concern-
ing the outcomes of patients subjected to protective,
low-volume mechanical ventilation in the context of sig-
nificant acid-base status alterations. Hickling et al. [3]
adopted a low tidal volume ventilation strategy and
reported that the presence of acidemia (mean pH: 7.2)
was related to increased survival. This suggestion was
further supported by data originating from a 10-year
study [4]. Kregenow et al. [5] recently reported a meta-
analysis of the ARDS Network data concerning the
effect of hypercapnic acidosis on survival using multi-
variate logistic-regression. The authors concluded that
hypercapnic acidosis resulted in reduced 28-day mortal-
ity even in patients ventilated with the injurious VT of
12 ml/kg. However, this finding was not demonstrated
when analysis was applied in the low VT (6 ml/kg)
group.
A growing body of literature reports on diverse biolo-
gical effects of hypercapnic acidosis in animal models.
Shibata et al. [6] demonstrated that hypercapnic acidosis
exerts protective effects to a certain extent in an isolated
and perfused rabbit lung model of warm ischemia-reper-
fusion lung injury. In terms of capillary bed integrity,
ischemia-reperfusion injured lungs were protected when
hypercapnic acidosis was instituted, while HA did not
alter the capillary bed status of normal, uninjured lungs.
A hallmark experimental study on the effects of hyper-
capnic acidosis in a VILI model by Broccard et al. [7]
demonstrated that it decreased the severity of VILI in
an isolated rabbit lung model. Sinclair et al. [8] further
supported this finding by reporting such a protective
effect of hypercapnic acidosis in an in-vivo intact rabbit
VILI model.
Another issue of interest is that of the role of acidosis
per se (non-CO2 derived) versus hypercapnic acidosis in
attenuation of VILI. In fact, experimental evidence sug-
gests that the actual protective effects of hypercapnic
acidosis are mediated by acidosis per se rather than
hypercapnia. Laffey et al. [9] focused on the effects of
hypercapnia vs acidosis per se in an ex-vivo model of
warm ischemia-reperfusion rabbit lung injury. They
demonstrated that both hypercapnic and normocapnic
acidosis were protective in that model, but that hyper-
capnic acidosis exerted a more pronounced effect. Of
interest, the protective effects of hypercapnic acidosis
were greatly reduced if it was buffered towards a normal
pH value. Moreover, Lang et al. [10] demonstrated that
buffered hypercapnia, i.e. hypercapnia at normal pH,
had a detrimental effect on the function of fetal rat
alveolar epithelial cells when these were incubated in a
cytokine-rich medium. On the other hand, the potential
of acidosis per se to exert protective effects in various
types of injury has been documented in other organ sys-
tems as well. For example, myocardial [11], brain [12]
and liver [13] protection have been shown to be effec-
tively mediated by metabolic acidosis.
Having these considerations in mind, we evaluated the
effects of hypercapnic (respiratory) versus normocapnic
(metabolic) acidosis in an ex-vivo rabbit lung model of
VILI. We tested the hypothesis that metabolic acidosis
is as protective as respiratory acidosis against VILI.
Methods
Perfusion circuit description
A previously described [14]ex-vivo isolated and perfused
rabbit lung model of VILI was used. However, this
model has been modified by our research group [15,16]
in order to allow more accurate and real-time monitor-
ing of the oxygenation and acid-base status of the perfu-
sion fluid.
Briefly, the model consisted of a perfusion circuit
incorporating the heart-lungs preparation. The perfusion
medium consisted of a custom-made perfusate [15] and
autologous blood. The circuit’s venous pool consisted of
a bottle containing the perfusion medium which was
directed towards the pulmonary circulation under the
drive of a mechanical pump (Masterflex 07550; Cole-
Parmer Instrument Co, IL, USA). An “efferent” tube was
inserted in the left atrium, and ended up over the
venous pool bottle “closing” the circuit. By voluntarily
adjusting the height of the end of the “efferent” tube,
the afterload of the pulmonary circulation could be
manipulated.
Blood pressure monitoring catheters were connected
to a calibrated monitoring system (Direc/NEP 201 B
Physiologic Recording System, Raytech Instruments Inc,
Vancouver, BC, Canada). Additionally, real time blood
gas measurement was carried out via a catheter inserted
to the “afferent” tube and connected to the respective
equipment (Trend Care, 7+™, TCM 7000, Diametrics
Medical Inc., Minnesota, USA). A gas mixture of CO2
(35-45%) and room air (65-55%) was insufflated into the
venous pool bottle achieving normocapnic conditions
and oxygen partial pressure at the 120-170 mmHg
range. Surgical extraction of the heart-lungs block and
incorporation of the preparation into the perfusion cir-
cuit was performed according to a previously described
technique [14]. According to the Greek legislation,
approval from the Veterinary Directorate of the Prefec-
ture of Athens in conformance to the 160/1991 Council
Directive of the European Union was obtained before
the beginning of the study. New Zealand white rabbits
were utilized. After extraction of the heart-lungs block
and through a small transverse incision at the right
ventricle, an “afferent” tube was inserted into the
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Respectively, a small transverse incision was made at the
apex of the heart and the “efferent” tube was advanced
into the left atrium and secured with sutures and a cot-
ton tape. Finally, the preparation was suspended from
an electronic balance (BG 025, Mark-10, NY, USA) and
connected to a ventilator (T-Bird AVS III, Thermo
Respiratory Group, CA, USA).
Measurements - Indices of lung injury
Lung injury was assessed using hemodynamic para-
meters as well as histology indices.
Weight gain
Weight gain represented solely the mass of the perfusate
leaking through the alveolar space-blood barrier, i.e. pul-
monary edema. Measurements of weight gain were
made during the 1-hour period of pressure controlled
ventilation (PCV) ventilation.
Ultrafiltration coefficient (Kf)
The integrity of the endothelium was assessed via its Kf
using the double occlusion technique, previously
described elsewhere [17,18].
Pulmonary artery pressure (PAP) changes
PAP measurements were recorded during the PCV
interval, at set time points (20 and 40 min of
ventilation).
Histology
Histology was performed on the left lung. Three tissue
slices were taken from the lung apex, hilum and base.
Four indices of histologic damage were evaluated simi-
larly to other studies [8]. Intra-alveolar as well as inter-
stitial hemorrhage, accumulation of inflammatory cells,
degree of alveolar remodelling and interstitial edema
were evaluated by a pathologist blinded to specimen
group allocation. After evaluation of each of these para-
meters, a cumulative lung injury score ranging from 0
to 3 was assigned to the specimen.
Ventilation - perfusion protocol
All preparations were initially perfused in normocapnic
conditions (pCO2 = 40 mmHg) and maintained at a
continuous positive airway pressure (CPAP) of 5
cmH2O. Initial flow was 30 ml/min and was progres-
sively increased to a steady value of 300 ml/min within
20 min. A 5-min period of compensation was allowed
(under CPAP = 5 cmH20) and an initial measurement
of the ultrafiltration coefficient - Kf (Kfbase) took place.
Within the next 30-min period under CPAP = 5
cmH2O, preparations were randomized to: (i) the con-
trol (C) group (pCO2 = 40 mmHg, pH = 7.4), (ii) the
hypercapnic, respiratory acidosis (RA) group (pCO2 =
100-130 mmHg, pH = 6.9-7.2) or (iii) the normocap-
nic, metabolic acidosis (MA) group (pCO2 =4 0
mmHg, pH = 6.9-7.2). Hypercapnic acidosis was
achieved by increasing the fraction of the CO2 insuf-
flated into the venous bottle from 35-45 to 60% while
metabolic acidosis was achieved by slowly infusing into
the perfusate medium approximately 2 ml of HCL
solution 0.5 N.
Once the desirable metabolic conditions were reached
and a second Kf (Kf1) measurement was obtained, the
second stage of randomization took place. This included
ventilation of the preparations of each metabolic group
(C, RA, MA) with high pressure (HP; PCV = 22 cm
H2O, PEEP = 3 cm H2O) or low pressure (LP; PCV =
12 cm H2O, PEEP = 3 cm H2O) (a total of 6 groups).
All preparations were then ventilated for 1 hour. At the
end of this period, a third Kf (Kf2) measurement was
performed and the ventilation-perfusion was terminated.
In addition, the preparation’s weight was measured in
order to calculate the initial lung weight. The latter was
calculated by subtracting the heart, connective tissue
and tracheal tube weight from the initial preparation
weight, after removal of the lungs at the end of the
protocol.
In order to adjust for technical failures during the
delicate surgical maneuvers, heart-lungs preparations
macroscopically damaged during their surgical extrac-
tion, exhibiting vascular failure during the 5-min com-
pensation period or the first 5 minutes of PCV
ventilation were excluded from the analysis. In addition,
if - during the 60-min period of PCV ventilation - the
heart-lungs preparations exhibited visible edema over-
flow from the tracheal tube due to obvious failure of the
lungs’ vascular beds, the ventilation-perfusion was termi-
nated. In that case, the last recorded readings of weight
and PAP were included in the analysis but Kf2 could
not be performed nor change in ultrafiltration coeffi-
cient (dKf) could be calculated.
Statistical analysis
Two-way (analysis for two independent variables and
their interaction) ANOVA was used for multiple com-
parisons of physiologic indices of lung injury (weight
gain, Kf changes as well as injury scores) for between
group comparisons with least significance difference
(LSD) test for within-group comparisons.
Results
The initial protocol included 60 preparations. Of these,
2 were not included in the analysis secondary to early
(within the first 5 minutes) vascular failure and 1
because of macroscopic damage in accordance to the
above criteria. 22 preparations demonstrated vascular
failure and their ventilation was interrupted at some
point throughout the protocol. All animals as well as
heart-lungs preparations were similar concerning their
baseline characteristics (Table 1).
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Both inspiratory pressure (P < 0.001) and pH status (P =
0.025) as well as their interaction (P = 0.024) signifi-
cantly influenced weight gain. Specifically, the HPC
group gained significantly greater weight than the
HPMA, the HPRA and all LP groups. No difference was
observed between the HPMA and HPRA groups regard-
ing weight gain (figure 1).
Ultrafiltration coefficient changes
In neither group did the dKf seem to be affected by pH
(P = 0.383), pressure (P = 0.791) or their interaction
(P = 0.087) (figure 2). These data are derived from 35
animals (3 for HPC, 4 for HPRA, 2 for HPMA, 8 for
LPC, 9 for LPRA and 7 for LPMA group) since 22
demonstrated vascular failure, as stated above. It is true
that dKf was lower with both for hypercapnic and
metabolic acidosis groups, but that these differences
were not statistically significant between the two.
Pulmonary artery pressure changes
After 20 min of ventilation, the HPMA group demon-
strated significantly increased dPAP than HPRA and
HPC groups (P = 0.0276). The same applied after
40 min of ventilation (P = 0.0012) (Table 2).
Repeated measures ANOVA revealed that HPMA
group demonstrated significantly increased dPAP vs the
HPC group (p = 0.003) while there was no difference
compared with the HPRA group (p = 0.952).
Histology
Hemorrhage was the most prominent finding in the HP
groups implying the development of VILI in HP groups
(Figure 3). Macrophages were significantly accumulated
only when hemorrhage was a major finding (Figure 4).
Interstitial edema was a significant finding, more
obvious around main bronchi and hilar vessels (Figure
5). Analysis of the lung injury scores demonstrated sig-
nificantly greater injury scores for HP vs LP groups (P
<0.001). However, pH did not seem to influence injury
scores neither for HP nor for LP groups (P = 0.164).
The latter also applied for their interaction (P =0 . 8 4 6 )
(Table 2).
Discussion
The major finding of our work was that normocapnic-
metabolic acidosis was as effective as hypercapnic-
respiratory acidosis in the prevention of pulmonary
edema formation, a major manifestation of ventilator-
induced lung injury. This pilot study implies that acido-
sis per se - either metabolic or respiratory - exerts a pro-
tective effect on experimental VILI in the isolated
ventilated-perfused rabbit lung model.
Table 1 Characteristics of animals and heart-lungs preparations at baseline
Variables HPC n=
10
HPRA n=
10
HPMA n=
10
LPC n=1 0 LPRA n=
10
LPMA n=
10
P
value
Animal weight, kg 3.3 ± 1.0 3.2 ± 1.0 3,0 ± 0.9 3,2 ± 0.8 3,2 ± 0.8 3.2 ± 0.8 0.42
Lung weight, g 19.6 ± 1.6 20.6 ± 1.2 21.4 ± 1.2 22.0 ± 1.2 20.4 ± 1.0 21.3 ± 1.4 0.79
Ischemic time , min 37.2 ± 2.3 34.0 ± 2.6 29.7 ± 1.4 33.2 ± 1.5 32.2 ± 2.4 30.4 ± 1.0 0.11
pH 7.42 ± 0.02 7.42 ± 0.01 7.43 ± 0.02 7.43 ± 0.01 7.41 ± 0.02 7.58 ± 0.15 0.56
pCO2, mmHg 35.9 ± 4.2 37.2 ± 2.0 37.3 ± 3.5 38.1 ± 2.2 39.1 ± 1.7 36.7 ± 1.4 0.47
pO2, mmHg 175.3 ±
15.2
159.4 ± 7.4 168.1 ± 16.4 157.3 ±
14.5
218.0 ± 30.3 156.3 ± 10.5 0.11
T, °C 36.2 ± 0.1 36.4 ± 0.1 36.1 ± 0.1 36.3 ± 0.1 36.3 ± 0.1 36.3 ± 0.1 0.77
Mean pulmonary artery pressure, mmHg 16.7 ± 0.9 15.2 ± 1.8 18.3 ± 1.3 16.7 ± 2,3 14.0 ± 1.90 19.6 ± 1.2 0.02
Ultrafiltration coefficient, Kfbase, g/min/mm Hg/100
g
0.36 ± 0.18 0.19 ± 0.06 0.24 ± 0.05 0.60 ± 0.39 0.25 ± 0.04 0.20 ± 0.03 0.54
All values expressed as mean ± SEM.
No statistically significant differences were observed.
HPC: high-pressure control (normocapnic); HPRA: high-pressure respiratory acidosis (hypercapnic); HPMA: high-pressure metabolic acidosis; LPC: low-pressure
control (normocapnic); LPRA: low-pressure respiratory acidosis (hypercapnic); LPMA: low-pressure metabolic acidosis.
Figure 1 Effects of metabolic acidosis on VILI attenuation in
the HP ventilation group, in terms of weight gain i.e.
pulmonary edema formation. HPC group preparations gained
significantly greater weight than their acidotic counterparts;
however, both metabolic and hypercapnic acidosis had the same
protective effect on weight gain
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cal ventilation often leads to an increase of arterial CO2
levels which - if not corrected by the physician - is
called permissive hypercapnia and has been shown to
affect multiple biological system targets. As far as lung
injury is concerned, hypercapnia has effect on surfactant
production [19], vascular permeability modulation [20]
and NO regulation [21]; in this way, it is able to modify
the severity of VILI. Overall, the current concept con-
cerning the behavior of ventilator-injured lungs in the
context of hypercapnia is that the latter exerts a protec-
tive role at least at some degree, leading to attenuated
blood-gas barrier damage and therefore less pulmonary
edema formation.
Broccard et al suggested the protective role of hyper-
capnic acidosis on ventilator-injured isolated rabbit lung
preparations [7], a finding latter extended to the intact
rabbit lung model [8]. However, to date hypercapnia has
been mostly studied in relation to the concomitant
acidosis it causes and - to our knowledge - few data
exist concerning the effects of metabolic acidosis on
VILI.
Laffey et al evaluated the effects of metabolic acidosis
vs hypercapnic acidosis on an isolated ex vivo rabbit
lung model of warm ischemia-reperfusion injury [9].
The investigators concluded that even though both
hypercapnic and metabolic acidosis decrease the severity
of ischemia-reperfusion injury, hypercapnic acidosis is
more effective in doing so, a fact probably attributed to
the rapid intracellular distribution of carbon dioxide ver-
sus hydrogen ions. Nomura et al concluded that hyper-
capnic, but not metabolic, acidosis improved functional
recovery after cold cardioplegic ischemia in neonatal
lamb hearts [22]. These data suggest acidosis as an
important protective factor for various organs, mostly
when it is CO2-derived, underlining the possible syner-
gistic effects of CO2 and H
+ ions.
On the other hand, the work by Laffey et al [9] is
probably the single study presenting data on the differ-
ential effects of hypercapnic and metabolic acidosis on
lung tissue, yielding the need for further investigation.
The latter experimental series is different from our
study in several points. First, the type of lung injury is
different (warm ischemia-reperfusion versus VILI). Sec-
ond, the used tidal volumes were significantly different
between the two studies. We used rather excessive VT
(approximately 30 ml/kg) and pressures (peak 25
cmH2O) to achieve VILI (versus a VT of 4 ml/kg).
Third, perfusate flow through the lung’s capillary bed
was greater in our study (300 vs 150 ml/min). Increased
vascular flow is suggested to promote lung edema in the
context of VILI [17]. Taking into account these consid-
erations, it seems that we employed more injurious pat-
terns of both ventilation and perfusion apart from
elaborating on a different type of lung injury. Addition-
ally, potential adverse effects of CO2 on certain settings
(e.g. its contraindication in cases of increased intracra-
nial pressure or concerns for retardation of normal
Figure 2 Effects of metabolic acidosis on VILI attenuation in the HP ventilation group in terms of PAP changes. After 20 and 40 min the
HPMA group demonstrated significantly increased dPAP than its RA and C counterparts
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[23] do exist. It is therefore justified to further elucidate
the role of various types of acidosis on VILI and the
potential for their therapeutic use in this clinical setting.
Based on previous hypotheses, one would expect
hypercapnic acidosis to be more protective than meta-
bolic acidosis. However, this was not the case in our
series at least in terms of edema formation. A possible
explanation for these finding could be the effect of
acidosis on pulmonary vasculature. As opposed to the
systemic circulation, pulmonary vasculature seems to be
resistant to the vasodilator effects of acidosis [24]. Bri-
mioulle et al [25] demonstrated that metabolic acidosis
aggravated hypoxia-induced pulmonary artery vasocon-
striction, a finding not evident with respiratory acidosis.
Sada et al [26] reported on the vasoconstrictor effects of
lactic acid-induced acidosis on the pulmonary artery of
anesthetized cats. Further, acidosis seems to offset vaso-
dilator effects of CO2 in the pulmonary vasculature [24];
a net vasoconstrictor effect is probably further accentu-
ated when CO2 is absent. This consideration is partially
supported by our results, where the high pressure-meta-
bolic acidosis group demonstrated significantly higher
increase of the mean pulmonary artery pressure than
the high pressure-respiratory acidosis and control
groups after 20 and 40 min of ventilation. Interestingly,
the high pressure-respiratory acidosis group demon-
strated consistently small increases of the mean pulmon-
ary artery pressure; this confirms the counteracting
effects of CO2 and acidosis on pulmonary vasculature,
as suggested by other studies. By preventing the dilata-
tion of pulmonary vasculature, thereby inhibiting abun-
dant increase in hydrostatic drive/blood pooling in
pulmonary capillaries, acidosis could probably represent
a determinant of VILI attenuation.
Project limitations and clinical significance of the
experimental model
The isolated-perfused rabbit lung model used offers the
ability to study the effect of several factors on lung par-
enchyma without the confounding effects of other
organs, such as the kidney. However, this experimental
strategy carries certain limitations concerning the ability
to extrapolate results into clinical practice, already
described in detail elsewhere [7]. Of note, the extra-
thoracic location of the lungs aggravates the hyper-
expansion of lung preparation probably generating even
worse concomitant adverse outcomes-which is probably
clinically irrelevant.
Figure 3 Effects of HP (1A) vs LP (1B) ventilation on lung
parenchyma-magnificationx20. Disruption of vascular spaces and
interstitial edema are more prominent in the HP ventilation group
confirming the occurrence of VILI in this group
Table 2 Changes in mean pulmonary artery pressure at different time points during the ventilation protocol and
histology scores
Variables HPC n=9 HPRA n=1 0 HPMA n=9 LPC n=1 0 LPRA n=9 LPMA n=1 0
dPAP20, mmHg 8.5 ± 2.3 3,9 ± 1,9 16.7 ± 3.1 0.7 ± 1.0 0.2 ± 0.5 2.7 ± 1.7
dPAP40, mmHg 11.4 ± 2.7 10,8 ± 3.5 35.4 ± 9.9 3.2 ± 1.0 0.8 ± 0.5 5.1 ± 2.1
All values are expressed as mean ± SEM.
n = preparations included in the study.
HPC: high-pressure control (normocapnic); HPRA: high-pressure respiratory acidosis (hypercapnic); HPMA: high-pressure metabolic acidosis; LPC: low-pressure
control (normocapnic); LPRA: low-pressure respiratory acidosis (hypercapnic); LPMA: low-pressure metabolic acidosis; dKf: difference in ultrafiltration coefficient
before and after the 1-hr ventilation-perfusion protocol; dPAP20: difference in mean pulmonary artery pressure after 20 min of ventilation; dPAP40: difference in
mean pulmonary artery pressure after 40 min of ventilation-perfusion.
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important effect of respiratory acidosis on capillary per-
meability, as indicated by dKf. It seems to be a contrast
between the reduced weight gain and the absence of
effect on dKf between HPMA/HPRA and HPC groups.
A reasonable explanation is that a limited number of
HP preparations actually tolerated the 1-hr period of
ventilation-perfusion and, therefore, were eligible for the
measurement of Kf2 and dKf; thus, data on dKf were
limited and, presumably, lacked power to reveal such a
difference (type b error). In Figure 2, we presented
detailed data on dKf to show that HPC group exhibited
a larger increase (an order of magnitude) in its Kf, the
measure of the ultrafiltration coefficient, compared with
both the HP-acidosis groups (respiratory and metabolic).
This change paralleled the weight gain difference
between these groups that was observed in a larger
number of preparations.
It would be interesting to note that in regard to the
effects of hypercapnic acidosis, the severity of injury
might be important. The beneficial effects of hypercap-
nic acidosis are most pronounced in severe experimental
VILI [6,7] while they are not so impressive on more
clinically relevant models [27]. In addition, they appear
to be absent in the setting of mild experimental VILI
[28] or atelectasis [29]. Whether this is the case for
metabolic acidosis is unknown, it is reasonable however
to speculate that in light of these data a rather more
severe model would be required to demonstrate the pro-
tective effects of metabolic acidosis.
It is now well documented that inflammatory changes
occur in the lung subjected to injurious ventilation
modes [30,31]. These changes are mediated by pro-
inflammatory cytokines, detected both in the circulation
and lung. Since this was a pilot study, elaborating on
the possible physiologic effects of acidosis per se in
VILI, inflammatory load was not initially addressed.
However, in light of our results the latter constitutes a
challenging future orientation.
Conclusion
Our study findings suggest that metabolic, normocapnic
acidosis is as protective as hypercapnic acidosis, at least
in terms of pulmonary edema formation, in an ex-vivo
rabbit lung model of VILI. This may imply that acidosis
and carbon dioxide levels may exert independent effects
on the attenuation of ventilator-induced lung injury.
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Figure 4 Effects of HP ventilation on macrophage
accumulation and intralveolar hemorrhage
(magnificationx400). These effects were much mor prominent on
the HP ventilation group indicating its noxious effects on normal
alveolar anatomy
Figure 5 Localization of interstitial edema in the HP ventilation
group. Large bronchi and hilar vessels were the main areas of
edema formation, a phenomenon consistent in the HP ventilation
group
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